BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness

Contributed by: Business Wire

Tags

Medical Devices

Health

Diabetes

Surgery

Health Technology

Clinical Trials

Truffle Capital

More Like This

Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure

Nitinotes Announces FDA IDE Approval to Initiate Pivotal U.S. Trial of the EndoZip™ System for Endoscopic Sleeve Gastroplasty

GMA with MOVIVA®

GMA with MOVIVA®: setting new standards in endoscopic bariatric treatment

PR Newswire associated0

Morphic Medical Announces CE Mark for RESET® Endoscopic Device Therapy

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Implantica's RefluxStopTM, a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK

Implantica announces successful completion of first RefluxStop® procedures in the U.S.

PR Newswire associated0

Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial